Sign in

CIK 0001681682

  • Non-accelerated filer
  • Smaller reporting company

ENDRA Life Sciences Inc.

Sign in to watch
Ticker
NDRA
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
260579295
Phone
+1 734-335-0468
Business address
3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
Former names
Endra Inc.
  1. 4 Option exercise Chief Financial Officer acquired 5,000 shares (option exercise)
  2. 4 Option exercise Chief Executive Officer acquired 2,874 shares (option exercise)
  3. 4 Conversion Director acquired 11,386 shares (conversion)
  4. 4 Conversion Chief Financial Officer acquired 10,350 shares (conversion)
  5. 4 Conversion Chief Technology Officer acquired 51,747 shares (conversion)
  6. 4 Conversion Chief Executive Officer acquired 5,175 shares (conversion)
  7. 4 Open-market buy Director bought 5,000 shares at $0.92 ($4,600)
  8. 4 Open-market buy Director bought 10,000 shares at $0.90 ($9,000)
  9. 4 Open-market buy Director bought 5,000 shares at $0.90 ($4,500)
  10. 4 Open-market buy Director bought 10,000 shares at $0.91 ($9,100)
  11. 4 Open-market buy Director bought 10,000 shares at $0.85 ($8,500)
  12. 4 Open-market buy Director bought 10,000 shares at $0.82 ($8,200)
  13. 4 Open-market buy Director bought 10,000 shares at $0.78 ($7,800)
  14. 4 Open-market buy Director bought 10,000 shares at $0.71 ($7,100)
  15. 4 Grant or award Director acquired 41,587 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 42,857 shares (grant or award)
  18. 4 Grant or award Director acquired 42,857 shares (grant or award)
  19. 4 Grant or award Director acquired 42,857 shares (grant or award)
  20. 4 Grant or award Director acquired 42,857 shares (grant or award)

Page 5 of 9 · 174 filings